1 Université Paris-Saclay, Hypertension Pulmonaire: Physiopathology and Innovation Thérapeutique, HPPIT, Faculté de Médecine, Le Kremlin-Bicêtre, France.
2 INSERM UMR_S 999, HPPIT, Le Kremlin-Bicêtre, France.
3 Department of Respiratory and Intensive Care Medicine, Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, ERN-LUNG, Le Kremlin-Bicêtre, France.
4 Department for Respiratory Medicine and Infectious Diseases and German Centre of Lung Research (DZL), Hannover Medical School, Hannover, Germany.
5 Université Paris-Saclay, Hypertension Pulmonaire: Physiopathology and Innovation Thérapeutique, HPPIT, Faculté de Médecine, Le Kremlin-Bicêtre, France [email protected].
Proteomic analysis of circulating biomarkers reveals that sotatercept's impact extends beyond activins to influence BMP-9 and BMP-10, along with essential metabolic and inflammatory factorshttps://bit.ly/3Z5AZJ3